drugset / Trial / NCT05447260
A New Prognostic Stratification-based Safety and Efficacy Study of Ruxolitinib in Myelofibrosis
NaSingle-groupOpen-labelTreatment
Summary
This is a multi-center, prospective, single-arm study to assess safety and efficacy of Ruxolitinib in myelofibrosis (MF) based on a new prognostic stratification.
Timeline
- Start
- 2022-06-10
- Primary completion
- 2022-12-10
- Completion
- 2023-12-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ruxolitinib | Small molecule | — | — |